Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ATRA
RLYB
Add up to 3 more stocks
ATRA
Atara Biotherapeutics, Inc.
+0.53%
$9.45+0.05Delayed quote: Oct 6, 2026, 2:15 PM EDT
Market Cap
$85.15M
52W Range
$3.92 - $19.15
RLYB
Rallybio Corporation
+0.65%
$17.01+0.11Delayed quote: Oct 6, 2026, 2:09 PM EDT
Market Cap
$90.27M
52W Range
$3.67 - $17.57
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 2.18 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 0.96 |
| P/S Ratio | 13.75 | 139.74 |
| P/FCF Ratio | N/A | 3.43 |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 82.4% | 89.3% |
| Operating Margin | 29.7% | -3270.9% |
| Net Margin | -269.4% | 7051.2% |
| ROE | N/A | 48.2% |
| ROA | -79.4% | 46.5% |
| ROIC | -100.3% | -24.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.98 | 27.26 |
| Quick Ratio | 1.98 | 27.26 |
| Debt/Equity | N/A | 0.00 |
| Interest Coverage | 9.46 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.